Print

HPTN 077 & ECLAIR

A Phase IIa Study to Evaluate the Safety, Tolerability and Pharmacokinetics of the Investigational Injectable HIV Integrase Inhibitor, GSK1265744, in HIV-uninfected Men and Women

Trial Details:

IIa Ongoing
National Institute of Allergy and Infectious Diseases (NIAID) February 01, 2015
Cabotegravir
Cabotegravir
Brazil, USA, South Africa, Malawi
NCT02178800; NCT02076178
https://clinicaltrials.gov/ct2/show/NCT02178800?term=NCT02178800&rank=1